Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

SELL
$47.76 - $82.86 $12.6 Million - $21.8 Million
-263,377 Reduced 76.81%
79,495 $6.56 Million
Q4 2022

Feb 10, 2023

BUY
$48.76 - $77.67 $5.54 Million - $8.83 Million
113,693 Added 49.61%
342,872 $17.5 Million
Q3 2022

Nov 01, 2022

BUY
$61.42 - $86.29 $6.27 Million - $8.81 Million
102,087 Added 80.33%
229,179 $16.1 Million
Q2 2022

Jul 29, 2022

BUY
$55.54 - $72.65 $7.06 Million - $9.23 Million
127,092 New
127,092 $8.39 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.63B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.